Close X
Attorney Spotlight

In addition to Mark Manner's busy corporate legal practice, he has established himself as a respected and avid astronomer. Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Blueprint for an IPO

Companies go public to raise capital to fuel growth, pay down debt and provide liquidity to shareholders. Although all issuers and offerings are different, the basic process of going public remains relatively constant. Blueprint for an IPO identifies the key players, details the process and identifies the obligations companies will face after going public.

Read now

Healthcare Fraud, Law360 Health Group of the Year 2017

Healthcare Fraud & Abuse

Watch video to see how Bass, Berry and Sims can help companies from all sectors of healthcare navigate enforcement and compliance issues related to fraud and abuse.

No industry faces more government scrutiny related to fraud and abuse than healthcare. From whistleblower lawsuits under the False Claims Act to industrywide investigations spearheaded by the U.S. Department of Justice to ever-changing Medicare compliance requirements, healthcare companies are exposed to a wide range of investigations and enforcement actions by both federal and state officials.

With our base in Nashville, the nation's healthcare capital, and our office in Washington, D.C., our healthcare fraud and abuse attorneys understand both the business and the politics of healthcare. Our counsel goes beyond the legal issues to consider all of the operational and management issues a healthcare organization faces when a healthcare fraud and abuse matter arises.

Government Enforcement

Download Healthcare Fraud and Review 2016, written by Bass, Berry & Sims attorneysWe routinely represent healthcare providers faced with fraud and abuse enforcement actions by the government and litigation stemming from those enforcement efforts. Our practice is led by our Healthcare Fraud Task Force, which includes former members of the U.S. Department of Justice and a number of former Assistant U.S. Attorneys with significant experience handling healthcare fraud matters across the country. Our attorneys bring the knowledge of having worked inside the government, providing great insight into how HHS-OIG, U.S. Department of Justice and the various State Attorneys' General offices think about fraud and abuse in healthcare and the strategies they use to pursue these cases.

We provide healthcare clients with counsel and support for every sort of civil and criminal exposure, across all sectors of healthcare, including:

  • Alleged violations of various healthcare fraud and abuse laws such as the Stark Law and the Anti-Kickback Statute
  • Litigation arising under the False Claims Act
  • Alleged violations of the Food, Drug and Cosmetic Act
  • Medicare compliance, Medicaid compliance and audits (RAC audits, ZPIC audits)

These civil and criminal actions threaten enormous potential damages and exclusion from Medicare and Medicaid – a loss of revenue that could imperil the viability of a healthcare provider. The attorneys on our Healthcare Fraud Task Force understand the high stakes involved through years of experience and detailed knowledge of healthcare regulations and fraud and abuse laws and the agencies that enforce them.

News

View More

Related Experiences

View More

Related Professionals

NAME TITLE TELEPHONE CONTACT

Viewing 0 of 0 Results

View More

Publications

View More

Upcoming Events

Past Events

View More

Media Mentions

View More

Our healthcare attorneys encompass the multitude of legal specialties necessary to service one of the largest, most highly regulated industries in the United States. We bring our multidisciplinary, team approach to our representation of the following sectors and facilities:

  • Academic medical centers
  • Ambulatory surgery centers
  • Behavioral health
  • Cancer therapy
  • Clinical laboratories
  • Dermatology
  • Diagnostic imaging
  • Health plans, managed care companies and benefit management companies 
  • Healthcare information technology
  • Home health
  • Hospice
  • Hospitals and health systems
  • Life sciences
  • Managed care
  • Medical device
  • Nonprofit providers
  • Orthotics and prosthetics
  • Pharmaceuticals and pharmacies
  • Physician practices, outsourced physician services and management companies
  • Private equity
  • Revenue cycle management
  • Senior housing and long-term care
  • Specialty pharmacy and pharmaceuticals
  • Telemedicine
  • Urgent and retail care clinics
  • Wellness and disease management

Services

×

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.